Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$396K Buy
14,392
+2,612
+22% +$85.8K ﹤0.01% 1143
2026
Q1
$439K Sell
11,780
-2,965
-20% -$122K 0.01% 1016
2025
Q4
$696K Buy
14,745
+4,518
+44% +$195K 0.01% 775
2025
Q3
$428K Buy
10,227
+3,117
+44% +$137K 0.01% 1005
2025
Q2
$313K Sell
7,110
-585
-8% -$26.5K ﹤0.01% 1144
2025
Q1
$388K Buy
7,695
+2,303
+43% +$114K 0.01% 962
2024
Q4
$230K Sell
5,392
-154
-3% -$6.5K ﹤0.01% 1342
2024
Q3
$219K Buy
+5,546
New +$201K ﹤0.01% 1419

Other funds holding G

Choreo LLC's G Position: Q2 2026 in Review

Choreo LLC increased its Genpact (G) stake by 22% in Q2 2026, buying an estimated $85.8K and bringing the position to 14,392 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Choreo LLC first reported a position in G in Q3 2024 and has held it in 8 quarters since. The position peaked at $696K in Q4 2025. 480 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Choreo LLC held 14,392 shares of Genpact worth $396K as of Q2 2026.
  • Choreo LLC bought 2,612 Genpact shares in Q2 2026, an estimated $85.8K.
  • Genpact made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1143 holding.
  • Choreo LLC first reported a position in Genpact in Q3 2024 and has held it in 8 quarters since.
  • Choreo LLC's Genpact position peaked at $696K in Q4 2025.
  • 480 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.